VIE/GRF (VIE/GRF)

Vienna Stock Exchange: VIE/GRF · EUR

€10.8

+0.13 (+1.3%)· Recorded snapshot

Market cap	6.4B
Revenue (ttm)	7.4B
Net income (ttm)	452M
EPS (ttm)	€0.66
P/E (trailing)	16.4x
P/E (forward)	9.7x
Dividend	€0.07 (0.62%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.4B
Net income (ttm): 452M
EPS (ttm): €0.66
P/E (trailing): 16.4x
P/E (forward): 9.7x
Market cap: 6.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E9.7

P25 14.3P50 18.7P75 25.4

Trailing P/E16.4

P25 20.4P50 26.7P75 39.7

ROE6.9

P25 4.8P50 10.6P75 20.1

ROIC6.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/GRF indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

EUR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Spain
Country code	AT
Earnings date	2026-11-02
Employees	25,258
Employees change	1,200
Employees growth	5.04%
Enterprise value	EUR 17.7B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1909
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ES0171996087
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Market cap	EUR 6.4B
Next earnings date	2026-11-02
Price	EUR 10.79
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	vie/GRF
Website	https://www.grifols.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	46.01x
Average P/E ratio (3Y)	65.04x
Average P/E ratio (5Y)	68.61x
Earnings yield	6.12%
EV/Earnings	39.09x
EV/EBIT	13.13x
EV/EBITDA	10.26x
EV/FCF	21.63x
EV/Sales	2.38x
FCF / EV yield	4.62%
FCF yield	12.73%
Forward P/E	9.7x
Graham number	15.14747
Graham upside	40.38%
Lynch fair value	EUR 3.80
Lynch upside	-64.78%
P/B ratio	0.8x
P/E ratio	16.35x
P/FCF ratio	7.85x
P/OCF ratio	5.88x
P/S ratio	0.86x
Price/EBITDA ratio	3.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.18%
EBITDA margin	22.17%
Effective tax rate	19.16%
FCF margin	11.01%
Gross margin	37.79%
Operating margin	18.18%
Pretax margin	9%
Profit margin	6.09%
Profit per employee	EUR 17,895
Profitable quarters	13
Profitable years	22
Revenue per employee	EUR 293,808
ROA	4.23%
ROA (5Y)	2.87%
ROCE	7.56%
ROE	6.93%
ROE (5Y)	3.59%
ROIC	6.49%
ROIC (5Y)	4.43%
Tax / revenue	1.72%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	46.08%
EPS growth (Q)	32.86%
EPS growth 10Y	-1.77%
EPS growth 5Y	-7.4%
EPS growth quarters	7
EPS growth years	2
FCF growth	-1.99%
FCF growth (Q)	64.83%
FCF growth (QoQ)	177.59%
FCF growth 5Y	4.32%
Gross profit growth	-6.05%
Gross profit growth (Q)	-6.72%
Gross profit growth 3Y	6.1%
Gross profit growth 5Y	3.77%
Net income growth	51.81%
Net income growth (Q)	31.32%
Net income growth (QoQ)	110.96%
Net income growth 5Y	-7.49%
Net income growth quarters	7
Net income growth years	2
OCF growth	-1.45%
OCF growth (Q)	44.1%
OCF growth (QoQ)	106.36%
OCF growth 10Y	5.27%
OCF growth 5Y	3.72%
Operating income growth	-9.42%
Operating income growth (Q)	-9.91%
Operating income growth 3Y	21.43%
Operating income growth 5Y	5.93%
Revenue growth	-0.33%
Revenue growth (Q)	-0.91%
Revenue growth (QoQ)	10.24%
Revenue growth 10Y	6.41%
Revenue growth 3Y	4.63%
Revenue growth 5Y	7.37%
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -274M
Depreciation and amortization	EUR 296M
EBIT	EUR 1.3B
EBITDA	EUR 1.6B
EPS	EUR 0.66
Financing cash flow	EUR -639M
Free cash flow	EUR 817M
Gross profit	EUR 2.8B
Income taxes	EUR 128M
Investing cash flow	EUR -520M
Net borrowing	EUR -537M
Net cash flow	EUR -48M
Net income	EUR 452M
Operating income	EUR 1.3B
Revenue	EUR 7.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.12
Book value per share	EUR 8.15
Debt / EBITDA	5.42
Debt / equity	1.17
Debt / FCF	11.45
Goodwill	EUR 7B
Interest coverage	2.23
Long-term assets	EUR 14.8B
Long-term liabilities	EUR 9.9B
Net cash (debt)	EUR -8.8B
Net cash / market cap	-137.43%
Net debt / EBITDA	5.36
Net debt / equity	1.11
Net debt / FCF	10.79
Piotroski F-Score	6
Property, plant and equipment	EUR 4.1B
Shareholders' equity	EUR 8B
Tangible book value	EUR -4.3B
Tangible book value per share	EUR -6.28
Total assets	EUR 20.1B
Total cash	EUR 537M
Total debt	EUR 9.4B
Total liabilities	EUR 12.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current assets	EUR 5.3B
Current liabilities	EUR 2.2B
Current ratio	2.37
Inventory turnover	1.35
Net working capital	EUR 3.1B
Quick ratio	0.7
Working capital	EUR 3.1B
Working capital turnover	2.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.17%
Dividend growth	-45.08%
Dividend growth (3Y)	-46.09%
Dividend growth (5Y)	-30.98%
Dividend growth years	0
Dividend payment date	2026-07-02
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	EUR 0.07
Dividend yield	0.62%
Ex-dividend date	2026-06-30
Last dividend	EUR 0.07
Payout ratio	28.32%
Shareholder yield	-3.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 9.49
1D price change	1.27%
1M price change	12%
1M total return	12%
1W price change	6.15%
1W total return	6.15%
1Y price change	-5.43%
1Y return CAGR	-4.74%
1Y total return	-4.74%
20-day SMA	EUR 9.99
200-day SMA	EUR 9.71
3M price change	9.41%
3M total return	9.41%
3Y price change	-3.83%
3Y return CAGR	-0.74%
3Y total return	-2.21%
50-day SMA	EUR 9.88
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 11.65
52-week high date	2026-01-08
52-week low	EUR 8.48
52-week low date	2026-03-23
5Y price change	-45.91%
5Y return CAGR	-11.27%
5Y total return	-45%
6M price change	21.54%
6M total return	22.43%
All-time high	EUR 34.18
All-time high date	2020-02-20
All-time low	EUR 6.58
All-time low date	2024-03-06
Average true range (ATR)	EUR 0.20
Average volume	0
Change from 52-week high	-7.34%
Change from 52-week low	27.18%
Change from all-time high	-68.43%
Change from all-time low	64.08%
Change from open	1.84%
Day's gap	-0.56%
High price	EUR 10.79
Low price	EUR 10.60
Monthly RSI	51.82
Open price	EUR 10.60
Position in 52-week range	100%
Previous close	EUR 10.66
Price vs 150-day SMA	13.71%
Price vs 20-day SMA	8.04%
Price vs 200-day SMA	11.08%
Price vs 50-day SMA	9.25%
Relative volume	9.26
RSI	67.85
Sharpe ratio	-0.16
Sharpe ratio (3Y)	0.12
Sharpe ratio (5Y)	-0.12
Sortino ratio	-0.03
Sortino ratio (3Y)	0.26
Sortino ratio (5Y)	-0.05
Weekly RSI	65.9
YTD price change	-1.01%
YTD total return	-0.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	418.2M
Shares change (YoY)	4.17%
Shares held by insiders	0.15%
Shares held by institutions	50.53%

Deeper analysis on VIE/GRF

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/GRF report

Is a complete VIE/GRF research report available?

No complete published report is available for vie/GRF (VIE/GRF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/GRF (VIE/GRF)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/GRF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/GRF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/GRF

Frequently asked questions